Momelotinib in JAK2 inhibitor-naïve myelofibrosis: pros and cons

• by Naseema Gangat, Ayalew Tefferi

• May 7, 2025

CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

• April 13, 2026

• 2 min

Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali

• by Moussa Djimde, Charles Arama, Hamadoun Diakité, Mohamed Keita, Bouréma Koné, Bréhima Tembely, Mamadou D. Samaké, Balla Bagayoko, Mohamed B. Traoré, Japhet Kabalu Tshiongo, Noluthando Ntlapo, Alassane Dicko, Michel Vaillant, Petra F. Mens, Henk D. F. H. Schallig, Kassoum Kayentao

• January 27, 2026

Surgical Intervention for Emphysematous Osteomyelitis of the Spine in a Patient with Malnutrition and Anemia: A Unique Case Study

• by Junyu Zhang, Siqi Feng, Zhiqiang Liu, Kan Xie, Chunli Gu, Jun Shen, Yangbo Zhang, Yunlong Zhou

• January 19, 2026